Akoya Biosciences, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
AKYA on Nasdaq
Location
100 Campus Drive, 6 Th Floor, Marlborough, MA

Insiders trading volume in the past year

Akoya Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas A. Raffin Director $72.4M Jun 4, 2024
Matthew Winkler Director $4.41M Jun 4, 2024
Garry Nolan Director $2.48M Jun 1, 2023
Robert Shepler Director $2.23M Jun 4, 2024
Joseph Driscoll Chief Financial Officer $1.17M Dec 22, 2022
Brian McKelligon President and CEO, Director $714K -$30.7K -4.12% Mar 23, 2025
Frederic Pla Chief Operating Officer $582K Mar 23, 2024
Niro Ramachandran Chief Business Officer $488K Mar 23, 2025
John Frederick Ek Cfo $362K Apr 1, 2025
Pascal Bamford Chief Clinical Officer $336K Mar 1, 2025
Jennifer Kamocsay Chief Legal Officer $292K Mar 1, 2025
Marilee Moy Chief People Officer $89.5K Feb 23, 2023
Myla Lai Director $89.5K Jun 4, 2024
Ehab El-Gabry Chief Medical Officer $72.7K Feb 23, 2023
Scott Mendel Director Oct 2, 2024
Thomas Schnettler Director Jun 4, 2024

Recent Insider Transactions by Companies or Individuals for Akoya Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.